Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Greenwich LifeSciences, Inc.

NASDAQ: GLSI · Life Sciences · 1 alert · CIK 1799788

Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Greenwich LifeSciences, Inc. filings on SEC EDGAR ↗

4:40 PM ET 10-Q
Financial Results

Greenwich LifeSciences Q3 2026 Results: Net Loss of $5.81M, Loss Widens

Greenwich LifeSciences reported a net loss of $15.4 million for the nine months ended September 30, 2026, driven primarily by $14.2 million in research and development expenses for its breast cancer immunotherapy. The company raised $9.3 million through an ATM program during the period but issued a going concern warning due to its accumulated deficit of $102.6 million and limited cash reserves of $5.9 million.

Key figure
Net loss $5.81M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.